HYPOPHARYNX CANCER
Clinical trials for HYPOPHARYNX CANCER explained in plain language.
Never miss a new study
Get alerted when new HYPOPHARYNX CANCER trials appear
Sign up with your email to follow new studies for HYPOPHARYNX CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Drug attack on tough head & neck cancers
Disease control Recruiting nowThis study is testing whether a combination of two drugs, sacituzumab govitecan and cetuximab, can help control advanced head and neck cancer that has come back or spread after initial treatment. It will involve about 40 adults whose cancer has progressed despite standard therapy…
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New combo aims to sharpen cancer fight, spare healthy tissue
Disease control Recruiting nowThis large study is testing two ideas to improve treatment for certain head and neck cancers. It will see if using a smaller, more precise radiation area and/or adding a drug called ATRA (a form of vitamin A) works better than standard radiation alone. The goal is to better contr…
Matched conditions: HYPOPHARYNX CANCER
Phase: PHASE3 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC